is bpc-157 approved by fda or ema Oral vs Injectable BPC-157: Differences,
Description
CAS 62304-98-7View product Research notes

Advanced oxidation protein products inhibit differentiation and activate inflammation in 3T3-L1 preadipocytes

No amino acids being broken down or assembled breaks a fast, but all nine essential amino acids pass through the liver without being cleaved

IGF-1 LR3 amplifies this signal and keeps it active much longer
Oral and some research doses use micrograms
